Roche profits soar 34 percent yet outlook cautious
283402
BASEL, Switzerland  - Profits at Roche Holding AG leapt 34 percent in 2006 on strong sales of cancer treatments Herceptin and Avastin and flu drug Tamiflu but worries over future margins hit the stock on Wednesday.
732908
The company said fourth-quarter earnings rose 17 percent on higher sales of its Enbrel arthritis drug and Prevnar vaccine, but said generic competition would hit 2008 profit.
161514
Eli Lilly and Co  on Tuesday said fourth-quarter profit rose on higher-than-expected sales of its medicines, including strong demand for its newer treatments for depression, diabetes and cancer.
549877
The drug maker Schering-Plough Corporation said yesterday that its fourth-quarter profit surged 75 percent as strong sales of its cholesterol, arthritis and allergy medicines helped offset rising research and marketing spending.
621740
IBM  on Thursday forecast  2008 earnings well ahead of Wall Street expectations after  results showing a strong international performance, and its  shares rose 5 percent.
430003
Investment manager T. Rowe Price Group  Inc. TROW.O on Tuesday said its quarterly profit jumped 25  percent on an increase in investment advisory revenue.
29498
Despite its fourth-quarter loss, the pharmaceutical giantâs results topped Wall Street estimates, and its shares rose more than 5 percent.
154759
Boston Scientific Corp. BSX.N on  Tuesday said its quarterly net earnings rose as sales of its  new cardiovascular device bolstered results despite a costly  recall.
76053
Estee Lauder Cos Inc  reported a higher quarterly profit and stood by its 2008 outlook on Friday, counting on international sales and other measures to offset tighter consumer spending at home.
581460
Genentech announces positive second-quarter results, but investors remain worried.
398185
The drugmaker's Q2 boasts 12% earnings growth.
548484
GALLAHER group remained cautious on its European prospects yesterday, despite a 4.4 per cent rise in underlying pre-tax profit in the first half.
50770
Although Procter & Gamble and Colgate-Palmolive posted big jumps in quarterly profits, only P.& G. issued a cautious outlook in the face of rising commodity costs.
244712
Dow Chemical Co.'s DOW.N  third-quarter profit surged 86 percent on increased plastics  sales, but demand remains vulnerable to soaring energy costs,  the No. 1 U.S. chemicals maker said on Thursday.
87830
IBM  on Thursday forecast  2008 earnings well ahead of Wall Street expectations as strong  growth abroad made up for weaker results in the United States,  sending its shares up 5 percent.
469017
Merck & Co.  said on Monday that quarterly earnings rose 12 percent on strong demand for its newer vaccines and medicines, and raised its 2007 profit forecast, sending its shares up 4 percent.
271035
Wall Street was higher after a better-than-expected profit report at Research in Motion and on word that Merrill Lynch might have lined up a  cash infusion from a Singapore fund.